Trials / Completed
CompletedNCT01376154
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 342 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm efficacy and safety when administering lamivudine tablet alone in subjects with hepatitis B virus-induced liver cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lamivudine |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2009-12-01
- Completion
- 2011-02-01
- First posted
- 2011-06-20
- Last updated
- 2017-05-22
Source: ClinicalTrials.gov record NCT01376154. Inclusion in this directory is not an endorsement.